We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

162 hedge funds and large institutions have $629M invested in Emergent Biosolutions in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

1.73% more ownership

Funds ownership: 77.92% → 79.65% (+1.7%)

1% more funds holding

Funds holding: 160 → 162 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 57

4% less capital invested

Capital invested by funds: $655M → $629M (-$25.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
57
Reduced
57
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FMA
Fiduciary Management Associates
Illinois
+$14.9M
2
GC
Guggenheim Capital
Illinois
+$9.07M
3
GPP
Great Point Partners
Connecticut
+$6.64M
4
KCM
Kennedy Capital Management
Missouri
+$6M
5
CM
Castleark Management
Illinois
+$4.13M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$14.3M
2
PAM
Panagora Asset Management
Massachusetts
-$5.33M
3
GAM
Gotham Asset Management
New York
-$4.99M
4
Morgan Stanley
Morgan Stanley
New York
-$3.44M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
WBG
76
Wharton Business Group
Pennsylvania
$1M +$1.07M +46,927 New
First Trust Advisors
77
First Trust Advisors
Illinois
$979K -$731K -31,929 -41%
AllianceBernstein
78
AllianceBernstein
Tennessee
$946K – – –
TC
79
TFS Capital
Pennsylvania
$916K +$984K +42,981 New
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
$904K +$4.58K +200 +0.5%
OAM
81
Oxford Asset Management
United Kingdom
$903K -$2.12M -92,382 -69%
DIA
82
Dana Investment Advisors
Wisconsin
$885K +$137K +5,998 +17%
TA
83
Teachers Advisors
New York
$873K – – –
Allianz Asset Management
84
Allianz Asset Management
Germany
$857K +$483K +21,089 +110%
Swiss National Bank
85
Swiss National Bank
Switzerland
$829K – – –
TI
86
Turner Investments
Pennsylvania
$783K +$408K +17,820 +94%
MAM
87
Martingale Asset Management
Massachusetts
$753K – – –
GKIM
88
GW&K Investment Management
Massachusetts
$748K +$183K +7,980 +29%
BG
89
BlackRock Group
United Kingdom
$734K -$419K -18,296 -35%
Marshall Wace
90
Marshall Wace
United Kingdom
$703K -$2.51M -109,648 -77%
SIM
91
Spark Investment Management
New York
$673K -$939K -41,000 -56%
Morgan Stanley
92
Morgan Stanley
New York
$578K -$3.44M -150,277 -85%
TPSF
93
Texas Permanent School Fund
Texas
$565K -$77.2K -3,370 -11%
PNC Financial Services Group
94
PNC Financial Services Group
Pennsylvania
$558K +$498K +21,730 +492%
State of Tennessee, Department of Treasury
95
State of Tennessee, Department of Treasury
Tennessee
$552K – – –
DCM
96
Dupont Capital Management
Delaware
$526K – – –
JP Morgan Chase
97
JP Morgan Chase
New York
$520K +$30K +1,312 +6%
Tudor Investment Corp
98
Tudor Investment Corp
Connecticut
$511K -$124K -5,400 -18%
AIG
99
American International Group
New York
$478K +$2.02K +88 +0.4%
Bank of Montreal
100
Bank of Montreal
Ontario, Canada
$472K -$20.7K -904 -4%
2 3
4
5 6

EBS Hedge Fund Activity: Q3 2014 in Review

162 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2014, worth a combined $629M — down 3.9% from $655M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EBS positions and 14 closed out — a net gain of 2 holders — while 57 added to existing stakes and 57 trimmed.

The largest buyer was Fiduciary Management Associates, opening a new position worth an estimated $14.9M. The largest seller was Numeric Investors, exiting entirely with an estimated $14.3M sold.

  • 162 institutional investors held Emergent Biosolutions (EBS) as of Q3 2014, up from 160 in Q2 2014.
  • Funds reported $629M of Emergent Biosolutions stock for Q3 2014, down 3.9% quarter-over-quarter.
  • 16 funds opened new Emergent Biosolutions positions in Q3 2014 and 14 closed out, a net change of +2 holders.
  • The largest Emergent Biosolutions buyer in Q3 2014 was Fiduciary Management Associates, an estimated $14.9M added.
  • The largest Emergent Biosolutions seller in Q3 2014 was Numeric Investors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q3 2014.